Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Coronary artery disease is the underlying etiology of left ventricular dysfunction and arrhythmias in most patients who receive implantable cardioverter defibrillators (ICDs). The aim of this study was to assess the safety and feasibility of dobutamine stress echocardiography (DSE) in patients with an ICD. DSE (dobutamine up to 50 μg/kg/min, atropine up to 2 mg) was performed in 87 patients with an ICD and known or suspected coronary artery disease. The ICD was inactivated before the stress test and reactivated after the study; no serious complications occured. DSE is a safe and feasible method for evaluating myocardial ischemia in patients with an ICD.

Original languageEnglish (US)
Pages (from-to)475-477
Number of pages3
JournalAmerican Journal of Cardiology
Volume92
Issue number4
DOIs
StatePublished - Aug 15 2003

Fingerprint

Stress Echocardiography
Implantable Defibrillators
Safety
Coronary Artery Disease
Dobutamine
Left Ventricular Dysfunction
Atropine
Exercise Test
Myocardial Ischemia
Cardiac Arrhythmias

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{7518e21e8d1e434a82f77e2fd9014636,
title = "Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators",
abstract = "Coronary artery disease is the underlying etiology of left ventricular dysfunction and arrhythmias in most patients who receive implantable cardioverter defibrillators (ICDs). The aim of this study was to assess the safety and feasibility of dobutamine stress echocardiography (DSE) in patients with an ICD. DSE (dobutamine up to 50 μg/kg/min, atropine up to 2 mg) was performed in 87 patients with an ICD and known or suspected coronary artery disease. The ICD was inactivated before the stress test and reactivated after the study; no serious complications occured. DSE is a safe and feasible method for evaluating myocardial ischemia in patients with an ICD.",
author = "Abdou Elhendy and Windle, {John Robert} and Porter, {Thomas Richard}",
year = "2003",
month = "8",
day = "15",
doi = "10.1016/S0002-9149(03)00673-8",
language = "English (US)",
volume = "92",
pages = "475--477",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators

AU - Elhendy, Abdou

AU - Windle, John Robert

AU - Porter, Thomas Richard

PY - 2003/8/15

Y1 - 2003/8/15

N2 - Coronary artery disease is the underlying etiology of left ventricular dysfunction and arrhythmias in most patients who receive implantable cardioverter defibrillators (ICDs). The aim of this study was to assess the safety and feasibility of dobutamine stress echocardiography (DSE) in patients with an ICD. DSE (dobutamine up to 50 μg/kg/min, atropine up to 2 mg) was performed in 87 patients with an ICD and known or suspected coronary artery disease. The ICD was inactivated before the stress test and reactivated after the study; no serious complications occured. DSE is a safe and feasible method for evaluating myocardial ischemia in patients with an ICD.

AB - Coronary artery disease is the underlying etiology of left ventricular dysfunction and arrhythmias in most patients who receive implantable cardioverter defibrillators (ICDs). The aim of this study was to assess the safety and feasibility of dobutamine stress echocardiography (DSE) in patients with an ICD. DSE (dobutamine up to 50 μg/kg/min, atropine up to 2 mg) was performed in 87 patients with an ICD and known or suspected coronary artery disease. The ICD was inactivated before the stress test and reactivated after the study; no serious complications occured. DSE is a safe and feasible method for evaluating myocardial ischemia in patients with an ICD.

UR - http://www.scopus.com/inward/record.url?scp=0042063784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042063784&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(03)00673-8

DO - 10.1016/S0002-9149(03)00673-8

M3 - Article

C2 - 12914885

AN - SCOPUS:0042063784

VL - 92

SP - 475

EP - 477

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -